P. Mulliez et al., Pulmonary aspergillosis complicating chronic septic granulomatous disease.Treatment with itraconazole and interferon gamma, REV MAL RES, 17(5), 2000, pp. 975-978
A 20-year-old patient suffering from chronic granulomatous disease develope
d pulmonary aspergillosis with thoracic wall invasion. Treatment with itrac
onazole combined with 3-weekly injections of interferon gamma (INF gamma) i
mproved the patient's general state of health within two months. Functional
signs resolved totally and x-ray images continued to improve for 6 months.
INF gamma was withdrawn after 11 months and was replaced with cotrimoxasol
e. Itraconazole was continued in a long-term regimen. Four years after onse
t of treatment, the clinical status of the patient remained satisfactory an
d the radiological aspect was unchanged
Pulmonary aspergillosis affects up to 40% of patients suffering from chroni
c granulomatous disease. Mortality is high, to the order of 25%. The classi
cal treatment is based on amphotericin B, but this case points out the sign
ificant contribution of itraconazole as first-line therapy. This antimycoti
c has been suggested for prophylaxis. The combined use of INF gamma can be
discussed due to the uncertainties about its long-term effects and because
of the requirement for 3-weekly injections. High cost is another important
consideration.